Daré Bioscience

Daré Bioscience is a clinical-stage biopharmaceutical company based in San Diego, California, dedicated to developing innovative products for women's health. The company focuses on areas such as contraception, fertility, and sexual and vaginal health. Notable products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel for treating bacterial vaginosis, and Ovaprene, a hormone-free vaginal contraceptive. Another significant candidate is Sildenafil Cream, designed to address female sexual arousal disorder. Additionally, Daré is advancing several products that are in the early stages of development, such as DARE-HRT1, a hormone replacement therapy, and DARE-VVA1, aimed at treating vulvar vaginal atrophy in hormone-receptor positive breast cancer patients. The company also has pre-clinical candidates, including DARE-LARC1, which is intended for reversible contraception, and non-hormonal options for both men and women. Through its diverse portfolio, Daré Bioscience aims to expand treatment options and improve health outcomes for women.